1. Home
  2. NVCR vs AFYA Comparison

NVCR vs AFYA Comparison

Compare NVCR & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • AFYA
  • Stock Information
  • Founded
  • NVCR 2000
  • AFYA 1999
  • Country
  • NVCR Jersey
  • AFYA Brazil
  • Employees
  • NVCR N/A
  • AFYA N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • AFYA Other Consumer Services
  • Sector
  • NVCR Health Care
  • AFYA Real Estate
  • Exchange
  • NVCR Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • NVCR 1.8B
  • AFYA 1.6B
  • IPO Year
  • NVCR 2015
  • AFYA 2019
  • Fundamental
  • Price
  • NVCR $17.09
  • AFYA $16.26
  • Analyst Decision
  • NVCR Buy
  • AFYA Hold
  • Analyst Count
  • NVCR 5
  • AFYA 4
  • Target Price
  • NVCR $26.60
  • AFYA $21.13
  • AVG Volume (30 Days)
  • NVCR 885.3K
  • AFYA 120.1K
  • Earning Date
  • NVCR 10-30-2024
  • AFYA 11-13-2024
  • Dividend Yield
  • NVCR N/A
  • AFYA N/A
  • EPS Growth
  • NVCR N/A
  • AFYA 61.94
  • EPS
  • NVCR N/A
  • AFYA 1.17
  • Revenue
  • NVCR $577,738,000.00
  • AFYA $584,951,886.00
  • Revenue This Year
  • NVCR $19.13
  • AFYA $19.06
  • Revenue Next Year
  • NVCR $5.33
  • AFYA $11.30
  • P/E Ratio
  • NVCR N/A
  • AFYA $13.98
  • Revenue Growth
  • NVCR 14.63
  • AFYA 16.67
  • 52 Week Low
  • NVCR $11.29
  • AFYA $15.52
  • 52 Week High
  • NVCR $24.74
  • AFYA $22.48
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 52.30
  • AFYA 41.44
  • Support Level
  • NVCR $15.35
  • AFYA $15.52
  • Resistance Level
  • NVCR $17.35
  • AFYA $16.60
  • Average True Range (ATR)
  • NVCR 0.98
  • AFYA 0.54
  • MACD
  • NVCR -0.06
  • AFYA -0.15
  • Stochastic Oscillator
  • NVCR 52.41
  • AFYA 25.52

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

Share on Social Networks: